Early age-related maculopathy in the cardiovascular health study (Q44268950)

1 December 2017

title

Early age-related maculopathy in the cardiovascular health study (English)

1 reference

1 December 2017

1 reference

Ronald Klein

1

0 references

Lewis Kuller

4

object named as

Lewis H Kuller

1 reference

1 December 2017

Barbara E K Klein

2

1 reference

1 December 2017

Emily K Marino

3

1 reference

1 December 2017

Curt Furberg

5

1 reference

1 December 2017

Gregory L Burke

6

1 reference

1 December 2017

Larry D Hubbard

7

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

110

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

25-33

1 reference

Changes in visual acuity in a population. The Beaver Dam Eye Study

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Senile macular degeneration: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Association between drusen and some of the risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Risk factors in age-related maculopathy complicated by choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Systemic hypertension and age-related maculopathy in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Cataracts and macular degeneration in older Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Association of zinc and antioxidant nutrients with age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Dietary fat and age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The Cardiovascular Health Study: design and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Recruitment of adults 65 years and older as participants in the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The Wisconsin age-related maculopathy grading system

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The prevalence of age-related maculopathy by geographic region and ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Features of age-related macular degeneration in a black population. The Barbados Eye Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Race, macular degeneration, and the Macular Photocoagulation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Genetic heterogeneity of angiogenesis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901565-8

7 January 2021

10.1016/S0161-6420(02)01565-8

Identifiers

DOI

1 reference

1 December 2017

1 reference